Transplant diagnostics is an integral procedure in organ transplantation. This is performed to check the compatibility between donor and the recipient and it plays a crucial role at every stage of organ transplantation. Additionally, assist physician and surgeons during the overall procedure of transplantation to control the risk of organ failure or transplant rejection. Moreover, organ transplantation is performed in order to replace the non-functioning organ with functioning one to provide a normal life to the patient.

Market Dynamics

The increasing number of transplant procedures along with the increasing awareness leads to increased number of organ donors is primarily driving the market value. Technological advancements associated with the transplant diagnostics coupled with the increasing public-private funding for target research activities are supporting the market value. The rising prevalence of infectious diseases is further accelerating the market value. Moreover, the rising adoption of cross-matching and chimerism testing during pre & post-transplantation is anticipated to create potential demand during the estimated period from 2020 to 2027.

On the other side, lack of favorable reimbursement policies, high cost of organ transplant, social and ethical issues related to organ transplantation are some of the factors projected to hamper the growth over the forecast period.   

Reagents & Consumables accounted for the major share in the market

By product & service, the reagents & consumables segment is leading the global market owing to the increasing adoption of Reagents & Consumables as well as a repeat purchase. The segment is also projected to maintain its dominance over the estimated period from 2020 to 2027.

The market research study on “Transplant Diagnostics Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 – 2027”, offers a detailed insight into the global transplant diagnostics market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights into the global transplant diagnostics market, its product & service, technology, transplant type, end user, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global transplant diagnostics market size and volume, and segment markets by product & service, technology, transplant type, end user, and geography along with the information on companies operating in the market. The Transplant Diagnostics market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.

North America region accounted for the major share in 2019

North America is leading the market with a major share in terms of value. The region is also projected to maintain its dominance over the estimated period. The well-established healthcare infrastructure with the highly developed healthcare system is primarily driving the regional market value. High adoption of personalized medicines, availability of skilled professionals, high adoption of innovative transplant diagnostic technologies, the large volume of organ transplantation procedures performed, technological advancements coupled with the higher healthcare expenditure are other important factors supporting the regional market value. Apart from these, the presence of global players in the regional market such as Bio-Rad Laboratories, Inc., CareDx, Dickinson and Company, Hologic, Illumina, Inc., Immucor, Inc., and Luminex Corporation is further supporting the regional market value.

The players profiled in the report include BAG Healthcare, Becton, Biofortuna (UK), bioMérieux S.A., Bio-Rad Laboratories, Inc. (US), CareDx (US), Dickinson and Company (US), F. Hoffman-La Roche Ltd. (Switzerland), GenDx (Netherlands), Hologic (US), Illumina, Inc. (US), Immucor, Inc. (US), Luminex Corporation (US), QIAGEN N.V. (Netherlands), Takara Bio, and Thermo Fisher Scientific Inc. (US).

Market Segmentation

Market By Product & Service

• Reagents & Consumables
• Instruments
• Software & Services

Market By Technology

Molecular Assay

• PCR-based Molecular Assay
• Sequencing-based Molecular Assay

Non-molecular Assay

• Serological Assay
• Mixed Lymphocyte Culture Assay
  
  

Market By Transplant Type

Solid Organ Transplantation

• Kidney Transplantation
• Liver Transplantation
• Heart Transplantation
• Lung Transplantation
• Pancreas Transplantation
• Other Organ Transplantations

Stem Cell Transplantation

Soft Tissue Transplantation

Bone marrow Transplantation

Market By End User

• Independent Reference Laboratories
• Hospitals & Transplant Centers
• Research Laboratories & Academic Institutes

Market By Geography

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa